Novartis Hedges Its Bet On Fingolimod In MS

Submission of backup compound would come three years after filing of initial candidate.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet